본문으로 건너뛰기
← 뒤로

Adverse Histopathological Features in Colorectal Cancer Associated with KRAS rs61764370 SNP: A Preliminary Study.

1/5 보강
Biomedicines 📖 저널 OA 100% 2021: 1/1 OA 2022: 22/22 OA 2023: 20/20 OA 2024: 55/55 OA 2025: 152/152 OA 2026: 94/94 OA 2021~2026 2026 Vol.14(2)
Retraction 확인
출처

Berisha TC, Cucu MG, Calotă-Dobrescu A, Sosoi SS, Ciurea AM, Mehedințeanu AM, Stovicek PO, Schenker RA, Mirea CS, Cara ML, Burada F, Schenker M

📝 환자 설명용 한 줄

: The rs61764370 T>G single-nucleotide polymorphism (SNP), located in a let-7 microRNA binding site within the 3' untranslated region (3'UTR) of the gene, may modulate tumor aggressiveness by alteri

🔬 핵심 임상 통계 (초록에서 자동 추출 — 원문 검증 권장)
  • 표본수 (n) 64

이 논문을 인용하기

↓ .bib ↓ .ris
APA Berisha TC, Cucu MG, et al. (2026). Adverse Histopathological Features in Colorectal Cancer Associated with KRAS rs61764370 SNP: A Preliminary Study.. Biomedicines, 14(2). https://doi.org/10.3390/biomedicines14020319
MLA Berisha TC, et al.. "Adverse Histopathological Features in Colorectal Cancer Associated with KRAS rs61764370 SNP: A Preliminary Study.." Biomedicines, vol. 14, no. 2, 2026.
PMID 41751217 ↗

Abstract

: The rs61764370 T>G single-nucleotide polymorphism (SNP), located in a let-7 microRNA binding site within the 3' untranslated region (3'UTR) of the gene, may modulate tumor aggressiveness by altering post-transcriptional gene regulation. This study evaluated its association with adverse histopathological features in colorectal cancer (CRC). : A preliminary study on 83 CRC patients carrying either the TT (wild-type, n = 64) or TG (heterozygous, n = 19) genotype was analyzed. Clinicopathological variables included patient sex, tumor location, American Joint Committee on Cancer (AJCC) staging system, histological grade, perineural invasion (PNI), and lymphovascular invasion (LVI). A composite "tumor aggressiveness" score was defined based on the presence of Grade 3 differentiation, LVI, and/or PNI. Group comparisons were performed using the Chi-square test or Fisher's exact test, as appropriate. : No statistically significant differences were observed in sex ( = 0.689), tumor location ( = 0.781), or stage at diagnosis ( = 0.812). Poorly differentiated tumors (Grade 3) were present in 20.3% of TT patients and absent in TG carriers ( = 0.06), while low-grade tumors (Grade 1) were more prevalent among TG patients (47.4%) compared to TT (29.7%). The composite high-aggressiveness score was lower in TG (36.8%) than in TT (48.4%), while co-occurrence of PNI and LVI was similar in both groups (~26%). : Although no significant associations were identified, TG carriers showed a tendency toward lower-grade, less aggressive tumors. Given the limited sample size, these findings should be interpreted with caution, necessitating larger cohorts in order to validate results.

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반

🟢 PMC 전문 열기